Site Search     
  A CHR Trial Investigation Outcomes of Exercise Training
  A Pull-Push Strategy for Lymphoma Immunotherapy
  Altered CD8+ T Cell Compartment in SLE Patients
  Biology and Diagnosis of HNPCC
  Center for Lupus Research
  CHAVI Innate Discovery
  Colon Cancer Prevention Program Project
  Consortium to Analyze Tolerogenic Dendritic Cells in Respiratory Syncytial Virus Infection
  Development of Neonatal Oxygen Therapy Information System to Support Oximetry Targets in Newborn Intensive Care Units
  Effect of S-adenosylmethionine on Blood Homocysteine
  Functional MR in Ischemic Cardiomyopathy
  Human Dendritic Cells and In Vivo Immunity to Biothreat
  Improving the Efficacy of Dendritic Cell Vaccines
  JC Virus and Tumor Formation in the Human Colon
  New Predictors of SLE Disease Activity
NIAID Cooperative Center Luminex Facility
  Rural Hospital Collaborative for Excellence Using IT
  Subpopulations of Human Dendritic Cells
  Targeting Langerhans Cells for Therapeutic Vaccination in Breast Cancer
  Transcriptional Signatures for Diagnosis of Different Spectra of Mycobacterium tuberculosis Infection and Characterization of the Immune Response during Latency or Active Disease
  Use of Microarrays to Understand Systemic Arthritis
NIAID Cooperative Center Luminex Facility
Grant Number: AI062623-02
PI: John Connolly
Funding Organization: National Institute of Allergy and Infectious Disease
Project Start: September 15, 2004
Project End: August 31, 2007
 
Abstract:

Multiplex protein arrays (Luminex) represent a powerful tool for high throughput monitoring of immune responses. However, this novel technology still suffers from many significant weaknesses.
- Different manufacturer kits provide different results for the same analyte.
- Large amount of data represents a bottleneck in the analysis process.
- The fixed costs associated with establishing a multiplex core render the methodology expensive.
We propose to establish at BIIR Dallas a Central NIAID Cooperative Centers Luminex Core Facility. This core will provide the following services to NIAID Cooperative Centers Investigators:
- Validate and standardize cytokine multiplex kits.
- Develop SOPs for assessment of cytokine levels in biological fluids.
- Develop novel methodologies for visualization and analysis of multiplex data.
- Assay samples at the lowest possible costs.
- Establish relationships with manufacturers.
- Organize Luminex technology training workshops.
The NIAID Cooperative Centers Luminex Core will offer state of the art Luminex technology to all Centers, permitting the generation of standardized data across all NIAID centers.